chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Suspected vaccination failure; pertussis 3 months after my tdap booster; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received DTPa (Reduced antigen) (Tdap Vaccine) for prophylaxis.   On an unknown date, the patient received Tdap Vaccine. On an unknown date, 3 months after receiving Tdap Vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and pertussis (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure and pertussis were unknown.   It was unknown if the reporter considered the vaccination failure and pertussis to be related to Tdap Vaccine.  Additional details were provided as follows: This case was reported by patient his/herself. The age at vaccination was not reported. The patient received booster dose of Tdap Vaccine. After receiving Tdap Vaccine, the patient caught pertussis. This case was considered as suspected vaccination failure, since the details regarding the laboratory confirmation for pertussis was not provided.
Chills, body aches for hours; Chills, body aches for hours; This is a spontaneous report from a contactable nurse, the patient. A 28-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration in the right arm on 26Dec2020 at 18:00 (at the age of 28-years-old) as a single dose for COVID-19 immunization. Medical history included depression, chronic pain, obesity. The patient was not pregnant at the time of vaccination. Concomitant medications included escitalopram oxalate (LEXAPRO), melatonin, fluticasone propionate (FLONASE), paracetamol (TYLENOL), and ibuprofen; all for unknown indications from unknown dates and unknown if ongoing. The patient previously took cefdinir (OMNICEF) and experienced allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 27Dec2020 at 5:00, the patient experienced chills and body aches for hours. The patient did not receive treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the chills and body aches for hours was not resolved.   Information on the lot/batch number has been requested.
Heartburn; Nauseous; Headache; Painful arm that was expected; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 14Apr2021 at 18:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications were not reported. Prior vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021 at 07:00, the patient was nauseous with heartburn, accompanied by headache and the patient expected painful arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcome of events nauseous, heartburn, headache and painful arm that was expected was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
pt recvd vax & 24 hrs p/vax exp tingling of feet;
This spontaneous report as received from a licensed practical nurse refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' medical history and concurrent conditions was provided. On unknown dates, the patients received unspecified doses of MMR II immunization series, lot number L024265, expiration date: 01-JUL-2017 and lot number L036853, expiration date: 24-SEP-2017, (dose, route of administration and injection site were not reported). There were no concomitant medications reported. It was stated that the vaccine underwent temperature excursion of 49.1 degrees Fahrenheit for 1 hour 7 minutes. The excursion was captured using digital data logger. No previous temperature excursion was reported. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (same flu like symptoms but was not intense as after the 1st dose.) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. No Medical History information was reported.On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (same flu like symptoms but was not intense as after the 1st dose.). At the time of the report, INFLUENZA LIKE ILLNESS (same flu like symptoms but was not intense as after the 1st dose.) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.No concomitant medication was reported. The treatment information was unknown.This case was linked to MOD-2021-395698,  MOD-2021-395584 (Patient Link).
Patient was fine until about 5 minutes post immunization, when he fainted.  He was unresponsive for about 8 minutes.  We wet his face with some water, laid him down on floor with feet up on chair, checked pulse, called 911.  They checked vitals and after he was awake he made the decision to not go to hospital.  Patient left with parents to go to their doctor.
PATIENT CALLED FOLLOWING DAY TO REPORT ALLEGED INCORRECT IMMUNIZATION LOCATION. STATES IT APPEARS TO BE NEAR COLLAR BONE AND FORWARD, ANATOMICALLY MISSING THE DELTOID LOCATION. PATIENT ALSO REPORTS HAVING A BOLUS THAT WOULD RESEMBLE SUBCUTANEOUS ADMINISTRATION
Fever of 104.8 gave Advil. Diarrhea extra fluids.
Sitting in chair at dialysis started to get extremely cold and shaking from the coed after being covered by 6 blankets.  Nurse took my temp and it was 102.9 Went to the ER was kept there for testing and released.
Tested positive covid-19; A spontaneous report was received from a healthcare professional, concerning a 41-years-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and developed tested positive covid-19.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 28 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 for prophylaxis of COVID-19 infection.  On 10 Jan 2021, the patient experienced tested positive covid-19.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events were not reported.   At the time of this report, the outcome of event was unknown.; Reporter's Comments: Although a temporal association exist, based on the natural history of COVID-19, the reported event o tested positive covid-19. is assessed as unlikely related with mRNA-1273. Patient most likely had COVID -19 infection as vaccine is not known to cause infection.
"Lightheaded", pale, diphoretic, faint. Laid pt. down for 15-20 minutes - ambulatory when left clinic.
On eve of 06/25/04, Nate developed a low grade fever. Slept fitfully for a few hours during night, developed high fever (ranging from 102.8 - 104 F) for most of 06/26/04. Tylenol and Motrin were administered regularly, would only bring fever down till 102.8 F. Was not able to sleep during the day (would sleep for maybe 20-25 minutes and then 'jerk' awake). Refused all food and drink. Slept fitfully for a few hours on eve of 06/26/09, then screamed (high pitched, nothing could comfort him. Screaming would increase if his head or legs were touched) from 10 pm till 7 am the next morning. Was listless for most of day on 06/27/04, again refused all food and drink. Continued to be not able to sleep during the day - would sleep for maybe 20-25 minutes, but his body and limbs would be jerking fitfully while doozing. Would awake disoriented, scream in panic. Finally was able to take some fluids on eve of 06/27/04, followed by some baby food. Slept for approximately 6-7 hours on eve/night of 06/27/04. Woke up fever free, but very tired, on morning of 06/28/04, has been steadily improving, getting back to his 'normal' behavior since.
"Moderna COVID-19 Vaccine EUA" Patient received 0.5ml instead of 0.25ml COVID booster dose.
Pt received Janssen vaccine on 4/13/21, and tested positive for COVID 15 days later.  Sx include Runny nose, sneezing, light headache
Extreme fatigue, chills (on an 84-degree day), almost falling asleep at desk
Temperature excursion for vaccine that was administered after excursion occured; This spontaneous report has been received from a nursing assistant concerning a patient of unknown age and gender. The patient's concomitant therapies, concurrent conditions, historical drugs and medical history were not reported.        On 07-AUG-2020,  the patient was vaccinated with one dose of varicella virus vaccine live (oka/merck)(VARIVAX)  formulation not provided but defaulted to subcutaneous injection, Lot # T002846 and  expiration date 23-JAN-2022  for prophylaxis (dosage regimen was not provided). The storage temperature was reported to had been at  -10.2°C for 1 hour and 53 minutes.            There was digital data logger involved and  no previous temperature excursion was reported.  This is one of multiple reports received from the same reporter.; Sender's Comments:  US-009507513-2008USA014798:AE case # 01697207 US-009507513-2008USA014950: US-009507513-2008USA014951: US-009507513-2008USA014705:AE case # 01697215 US-009507513-2008USA014806:AE Case # 01697206 US-009507513-2008USA015018:AE Case # 01697159 US-009507513-2008USA015035:AE Case # 01697212 US-009507513-2009USA000117:AE Case # 01697209 US-009507513-2009USA000132:AE Case # 01697205 US-009507513-2008USA014937:AE Case # 01697191 US-009507513-2009USA000113:AE Case # 01697199
Facial and cheek swelling on right side of face within 1-2 hours of injection.  Pain in left arm extending to neck within 1 day. Periodic mild chest pain. General disorientation within 1 hour of injection.
I was completely fine the day of and the next day in the morning developed chills, a fever of 100.1, and a headache. Took Tylenol but the fever continued to rise. By 12 noon it went up to 104. Contacted the immunologist on call   who prescribed antibiotics and took Naproxen with Celebrex 400 mg. Eventually by 9 pm or so the fever went down. Took Tylenol. In the middle of the night, I vomited. The next day started off with 99 and after taking another Tylenol, it did not come back. The headaches continued with fatigue for about 7-10 days. Currently working with the immunologist to figure out if I need to be pre medicated and post medicated before the 2nd shot.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 01/09/21 pfizer,Lot#012L20A 2nd dose: 02/06/21 Pfizer,Lot# 012M20A Diagnosed covid positive:08/10/21 Symptom onset:08/09/21 Exposure: Symptoms:SOB, Cough, muscle aches, fatigue, sore throat loss of smell/taste, chills, runny nose, headache.
No Adverse event; monovalent vaccine for 6-11 years old administered instead of bivalent vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (monovalent vaccine for 6-11 years old administered instead of bivalent vaccine) and NO ADVERSE EVENT (No Adverse event) in an 84-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR6965B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Oct-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 08-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (monovalent vaccine for 6-11 years old administered instead of bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (monovalent vaccine for 6-11 years old administered instead of bivalent vaccine) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (monovalent vaccine for 6-11 years old administered instead of bivalent vaccine).    No concomitant medication details was reported. It was reported that the patient received 0.5 ml of the dark blue cap vaccine for 6 to 11 years old instead of the new bivalent vaccine. No treatment medication details was reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-657547, US-MODERNATX, INC.-MOD-2022-657560 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-657560:Same reporter US-MODERNATX, INC.-MOD-2022-657547:
Information has been received from a registered nurse concerning a patient (age and gender not reported) who on an unspecified date was vaccinated with a dose of Gardasil (lot number unknown), injection. Concomitant medication not reported. The nurse reported that on an unspecified date the patient developed arthritic symptoms after receiving Gardasil. At the time of reporting it is unknown if the patient had recovered from the arthritic symptoms. Additional information has been requested.
Pt received 1 dose of Moderna COVID-19 vaccine on 4/1/2021.  He was initially seen at outside hospital ED for weakness, cough, and pain all over.  He had initially also tested positive for COVID-19 via PCR test on 5/30/2021. Treated for both COVID pneumonia and superimposed bacteria pneumonia.  Reported to live locally in a nursing home.  Pt was placed on a ventilator with IJ catheter on 6/8/2021.  Due to condition decline in condition, he was transferred to the Meriter ICU on 6/11/2021.  He has since been extubated, but currently remains in the ICU.
diarrhea daily; I have only taken the first shot about two years ago; This non-serious case was reported by a consumer via call center representative and described the occurrence of diarrhea in a 76-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received about two years ago).   On 23-MAR-2023, the patient received the 2nd dose of Shingrix (intramuscular, left deltoid). On 23-MAR-2023, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: I have only taken the first shot about two years ago). On an unknown date, the patient experienced diarrhea (Verbatim: diarrhea daily). The outcome of the diarrhea was not resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the diarrhea to be related to Shingrix.     It was unknown if the company considered the diarrhea to be related to Shingrix.   Additional Information: The age at vaccination was not applicable for this report. The patient received the 1st dose of Shingrix shot about two years ago and never knew that the patient had to take a 2nd shot, which led to incomplete course of vaccination. The patient asking what do the patient do now.  The Food and drug administration approved dosing schedule for Shingrix was the 1st dose at month 0, followed by a second dose 2 to 6 months after the first dose. the Centers for disease control and prevention has provided guidance that if it's been more than 6 months since you got the first dose, you should get the second dose as soon as possible. The patient do not need to restart the vaccine series. We advise that you talk to your healthcare provider about this guidance and your individual situation.   Follow-up information received on 13-MAR-2023: The reporter was the patient. The patient reported that he got a Shingrix shot two days ago, on Wednesday. The shot was given intramuscularly in the left deltoid.  The patient had been experiencing diarrhea and wondering if it could be due to Shingrix.  The diarrhea occurred daily and had not resolved. The reporter did not had the lot number. The patient was okay with contacting him or his physician. Summary of Changes: Patient demographics', product details for patient route of administration, anatomical location, Vaers details, event, time to onset, casuality and narrative was updated.
@ inj site, raised area approx 1" in diameter, redness, same size;2 days p/inj h/a, dizziness, T98.2;instructed to put heat on inj site;
Pt came in for a provider appt. and to catch up due to vaccine delay. Varicella was one of the vaccines needed. The provider ordered the vaccine. The MA brought the vaccine to me (LVN) to get it verified. During my verification I did not catch that the pt had received the MMR vaccine just 2 weeks prior on 4/11/23. Since it had not been 4 weeks since the previous live vaccine the pt should not have received the varicella that day.  The pt received the varicella vaccine and due to it being too soon it did not count as a viable vaccine requiring the pt to need to get the first dose again.
Restricted arm movement - pain - have been taking ibuprofen - after 2 mos. of pain saw my primary care was told vaccine went into a tendon and it would take months to resolve itself.
Patient got shingles on left scalp and neck only hours after the flu vaccine was administered /no prior history of shingles.
No symptoms, very mildly sore arm at site. 3 days later, had low 99.3 fever and chills in the middle of the night, woke up achy and arm very sore at site and nearby, felt run down and ?fluish?, fatigue since the dose, still ongoing.
Lost my sense of taste and smell day after 1st vaccine. Have not been able to recover. I received my 2nd dose today Sept 5, 2021
Shortly after getting the vaccine arm became swollen, hot, red, hard to the touch. Last night and this morning the redness started to spread to the elbow. Redness has spread to elbow and around the arm - biceps and triceps. Redness has spread below the vaccine site. Has not taken any oral medications or taken any other actions to alleviate issue.
Pfizer-BioNTech COVID-19 Vaccine EUA: Shortly after receiving Pfizer-BioNTech COVID-19 vaccine patient experienced dizziness and "shakiness" in extremities. No hives, no swelling, no shortness of breath, no chest pain, no loss of consciousness, no numbness, and no tingling noted at any time. Initial vital signs: blood pressure 140/78 mmHg, temperature 98.7 degrees Fahrenheit, pulse 106 beats per minute, respiratory rate 20 breaths per minute, oxygen saturation 98% on room air. Repeat vitals 14 minutes later: blood pressure 125/88 mmHg, temperature 98.6 degrees Fahrenheit, pulse 110 beats per minute, repiratory rate 18 breaths per minute, oxygen saturation 98% on room air. Thirty minutes after repeat vitals assessed patient stated they felt much better and able to leave clinic ambulatory with a steady gait. Patient was awake alert and oriented the entire time.
Itchy arms,; Red and small bumps; Headache; Body aches; This is a spontaneous report from a non-contactable consumer or other non-health care professional (patient). A 26-year-old female patient received unknown dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiration date: Unknown), via an unspecified route of administration on 30Mar2021 at 13:00 (at the age of 26-year-old) as single dose for COVID-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing. The patient had a history of allergy to lamb, dairy, corn and potatoes. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the COVID-19 vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient was not tested for COVID-19. On 30Mar2021 at 21:00, the patient experienced Itchy arms, red and small bumps, headache and body aches. The patient did not receive any treatment for the adverse events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of Itchy arms, red and small bumps, headache and body aches were resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.  Amendment: This follow-up report is being submitted to amend previously reported information: Treatment Received selected as No for Headache.
196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent).    No concomitant drug information was provided.  It was unknown if the patient had received any other vaccine 4 weeks prior to COVID-19 vaccine.  No treatment drug information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Follow-up received wherein Age group added and I narrative updated.
Patient reported lightheadedness, dizziness, and nausea.  Patients vitals were normal, and cleared by EMS.
Had vaccine on 1/7/2021 afternoon, the next morning and Saturday and Sunday developed difficulty breathing, dizziness, fatigue, headache and went to Medical Center ER was evaluated and a COVID test was done.  Results pending.  No blood work, CXR, or EKG was done.  Patient reports symptoms are now intermittent seem to be improving.  Patient will check on hospital website for COVID results